MedTrace Logo

Hyperuricemia and Left Ventricular Diastolic Function

NCT03495999 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 67

Last updated 2018-04-12

No results posted yet for this study

Summary

Metabolic syndrome and hyperuricemia were both associated with inflammation, leading to diversities of cardiovascular disease such as left ventricular diastolic dysfunction, but the relationship among these entities remained unclear. The aim of the present study focuses on the association among hyperuricemia, diastolic dysfunction and inflammatory biomarkers in apparently healthy individuals with metabolic syndrome

Conditions

  • Hyperuricemia
  • Metabolic Syndrome
  • Left Ventricular Diastolic Dysfunction

Interventions

DIAGNOSTIC_TEST

hyperuricemia

serum uric acid of 7mg/dl or more in men or 6mg/dl or more in women

Sponsors & Collaborators

  • National Defense Medical Center, Taiwan

    lead OTHER

Principal Investigators

  • Cheng-Wei Liu, M.D. · Tri-service General hospital, Songshan branch, National defense medical center

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-01
Primary Completion
2017-12-15
Completion
2018-04-03

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03495999 on ClinicalTrials.gov